Induced pluripotent stem cells
A scalable cell culture platform can generate universal red blood cells from stem cells, paving the way for manufacturing an abundant supply of blood for transfusions.
Low levels of sugar entering into pancreatic cells may be the culprit behind insulin secretion defects in early-onset diabetes.
From replacing the insulin producing cells of the body, to serving as genetic and drug screening platforms, stem cells could change the landscape of available treatments for diabetes.
Mutations in the gene HNF4A impair liver and pancreas development, indicating that maturity-onset diabetes of the young starts much earlier than initially thought.
A protein named GATA6 is key to the development of a normal pancreas in humans.
A*STAR researchers have devised a method to generate a renewable source of mature human Kupffer cells for liver toxicity bioassays.
The key to efficient production of heart muscle from pluripotent stem cells lies in optimizing the density and replicative state of the starting material
an eye to transfusion for patients, researchers are getting close to growing huge
numbers of red blood cells in industrial-grade vats
Kidney cells made from reprogrammed stem cells lead scientists to an accurate way to screen for toxic compounds
Cultured human embryonic stem cells given the ‘3iL’ treatment more closely resemble natural stem cells from the developing embryo